SAFESTEREO: phase II randomized trial to compare stereotactic radiosurgery with fractionated stereot...
SAFESTEREO: phase II randomized trial to compare stereotactic radiosurgery with fractionated stereotactic radiosurgery for brain metastases
About this item
Full title
Author / Creator
Crouzen, J A , Petoukhova, A L , Broekman, M L D , Fiocco, M , Fisscher, U J , Franssen, J H , Gadellaa-van Hooijdonk, C G M , Kerkhof, M , Kiderlen, M , Mast, M E , van Rij, C M , Nandoe Tewarie, R , van de Sande, M A E , van der Toorn, P P G , Vlasman, R , Vos, M J , van der Voort van Zyp, N C M G , Wiggenraad, R G J , Wiltink, L M and Zindler, J D
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Stereotactic radiosurgery (SRS) is a frequently chosen treatment for patients with brain metastases and the number of long-term survivors is increasing. Brain necrosis (e.g. radionecrosis) is the most important long-term side effect of the treatment. Retrospective studies show a lower risk of radionecrosis and local tumor recurrence after fractiona...
Alternative Titles
Full title
SAFESTEREO: phase II randomized trial to compare stereotactic radiosurgery with fractionated stereotactic radiosurgery for brain metastases
Authors, Artists and Contributors
Author / Creator
Petoukhova, A L
Broekman, M L D
Fiocco, M
Fisscher, U J
Franssen, J H
Gadellaa-van Hooijdonk, C G M
Kerkhof, M
Kiderlen, M
Mast, M E
van Rij, C M
Nandoe Tewarie, R
van de Sande, M A E
van der Toorn, P P G
Vlasman, R
Vos, M J
van der Voort van Zyp, N C M G
Wiggenraad, R G J
Wiltink, L M
Zindler, J D
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_2bbb8dbd654f4a569755b22184fa4a3a
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2bbb8dbd654f4a569755b22184fa4a3a
Other Identifiers
ISSN
1471-2407
E-ISSN
1471-2407
DOI
10.1186/s12885-023-10761-1
